Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03984695 · ClinicalTrials.gov registry record · NA

Sexual Health Empowerment for Women's Health

A NA study of Breast Cancer and Cervical Cancer, sponsored by University of Kansas Medical Center.

Active
Registry status
NA
Development phase
279
Enrollment target
1
Study location

NCT03984695 is a NA study of Breast Cancer and Cervical Cancer that is active but no longer recruiting, run by University of Kansas Medical Center. The registered enrollment target is 279 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03984695, a NA study of Breast Cancer and Cervical Cancer, is active but no longer recruiting, sponsored by University of Kansas Medical Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
279 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to expand the reach of an existing cervical cancer literacy and prevention intervention- the Sexual Health Empowerment (SHE) Project . As a logical extension of the investigators earlier work, the objective of this renewal is to expand reach of SHE to address women's health disparities more broadly to create a sustainable model for dissemination of health promotion interventions for vulnerable populations.

Interventions

  • BEHAVIORAL SHE-WOMEN

Study Locations (1)

Missouri

  • Jackson County Correctional Facility - Kansas City

Trial Details

FieldValue
Enrollment Target 279 participants
Start Date 2019-09-11
Est. Completion 2026-03-31
Phase NA

Sponsor

University of Kansas Medical Center

408 total trials

What the Registry Record Tells You About NCT03984695

The ClinicalTrials.gov registry entry for NCT03984695 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 279 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (90% lower). The listed sponsor is University of Kansas Medical Center, which has 408 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which SHE-WOMEN is the first listed.

NCT03984695 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03984695 about?

NCT03984695 is a clinical study titled "Sexual Health Empowerment for Women's Health". The purpose of this study is to expand the reach of an existing cervical cancer literacy and prevention intervention- the Sexual Health Empowerment (SHE) Project . As a logical extension of the investigators earlier work, the objective of this renewal is to expand reach of SHE to address women's hea...

What is the current status of trial NCT03984695?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 279 participants. The study started on 2019-09-11. Estimated completion is 2026-03-31.

What conditions does trial NCT03984695 study?

This clinical trial studies the following conditions: Breast Cancer, Cervical Cancer, Sexually Transmitted Diseases, Contraceptive Usage.

What interventions are being tested in trial NCT03984695?

The interventions under investigation include: SHE-WOMEN (BEHAVIORAL).

Who is sponsoring clinical trial NCT03984695?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03984695 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.